Stay Informed on Corporate Sustainability

Author: Jed Nykolle Harme

SGS ISL Ringaskiddy strengthens its commercial and client partnership capabilities with the appointment of Lisa Collins as Business Development Manager, bringing over 20 years of pharma and life sciences experience to support global demand for advanced analytical services, scientific collaboration, and high-quality client solutions.

Author: Jed Nykolle Harme

The pharma and life sciences sector is entering a period defined by strategic collaboration, capability expansion, and scientific innovation. This edition highlights initiatives that demonstrate how organisations are responding to evolving healthcare demands and global market dynamics. ‘SGS ISL expands commercial strength with appointment of Lisa Collins as Business Development Lead’ underscores the importance of commercial strategy in accelerating growth. The appointment reflects a sharpened focus on market engagement and the expanding demand for integrated life sciences services. In addition, 'Unlocking Scientific Capability with SGS Insourcing' highlights how internal capability expansion can enhance research agility and operational excellence. The initiative underscores the strategic value of strengthening scientific infrastructure to meet rising industry demands. Lastly, highlighting the sector’s top innovators, the 'Video Highlights of the Pharma Industry Awards 2025’ celebrate organisations and professionals driving research, operational excellence, and patient-focused initiatives, setting benchmarks for collaboration and impact and paving the way for the next wave of achievement at the 2026 awards. These stories illustrate a sector embracing collaboration, capability, and innovation. Organisations integrating these principles are positioned to deliver transformative, future-ready outcomes in pharma and life sciences.

Author: Jed Nykolle Harme

Relive the Pharma Industry Awards 2025 in the official highlights video, celebrating Ireland’s top pharmaceutical leaders, companies, and teams, while showcasing the ingenuity shaping the sector today.

Author: Jed Nykolle Harme

Success in the life sciences sector depends on having the right expertise at the right moment. Rising regulatory requirements, complex development programmes, and operational pressures mean companies need more than traditional staffing solutions.

Author: Pharmaceutical Technology

Denali secures $275m royalty funding from Royalty Pharma for tividenofusp alfa, supporting Hunter syndrome therapy development and TransportVehicle platform advancement ahead of FDA accelerated approval expected April 2026.

Author: News Medical Life Sciences

Rentschler Biopharma and Coriolis Pharma form a strategic collaboration, offering end-to-end biopharmaceutical solutions from formulation to commercial manufacturing, accelerating product development and enhancing efficiency across the global biologics value chain.

Author: Trinity College Dublin

Trinity launches ARC Hub for Therapeutics, a national initiative uniting academia, industry, and investors to accelerate biomedical research commercialisation, foster innovation, and develop next-generation therapeutics with real-world impact in Ireland.

Author: The Irish Independent

Poolbeg Pharma partners with Johnson & Johnson for UK POLB 001 cancer trial, aiming to prevent Cytokine Release Syndrome and improve patient outcomes in advanced immunotherapy treatments.

Author: Jed Nykolle Harme

The pharmaceutical and life sciences sector is undergoing sustained transformation driven by leadership, collaboration, and specialised talent. This edition highlights the forces propelling innovation and the mechanisms shaping the industry’s present and future. Strong leadership continues to shape the future of Ireland’s pharmaceutical sector. ‘Colin Rooney was named Pharma Leader of the Year' at the recently concluded Pharma Industry Awards 2025, demonstrating how strong leadership can drive sustainable growth across the sector. His recognition underscores the value of clear direction in advancing the next wave of innovators in 2026. Meanwhile, 'SGS strengthens Ireland’s lab talent pipeline' to support the growing life sciences sector demonstrates the importance of investing in skills and expertise. By equipping professionals with advanced capabilities, the industry remains agile amid evolving scientific, technological, and regulatory demands. Lastly, 'Frankfurt Airport strengthens global Pharma logistics' through Pharma.Aero partnership highlights the need for global collaboration and efficient infrastructure to ensure timely delivery of essential therapies while upholding quality and environmental standards. These developments underscore a core principle: resilience and growth rely on the convergence of leadership, talent, and strategic networks, offering both insight and optimism for the sector’s future.

Author: Business Wire

Meiji Seika Pharma invests in Lyric Bio to advance innovative IVIg biomanufacturing, supporting donor-independent production, accelerating R&D, and strengthening global supply of high-quality plasma-derived therapeutics.